Literature DB >> 9608324

Molecular biology of cartilage and bone destruction.

U Müller-Ladner1, R E Gay, S Gay.   

Abstract

Molecular biology has provided various new insights into the mechanisms operative in the pathogenesis of rheumatoid arthritis. Reflecting the unique character of rheumatoid synovium, advances have been achieved addressing the molecular changes taking place at the area of interaction between the aggressively growing synovium and the articular cartilage and bone. Key issues in the review period addressing this interaction were hyperplasia of rheumatoid arthritis synovium, mechanisms of activation and cell cycle regulation of synovial fibroblasts, pathways of synovial attachment to cartilage and bone, and the regulation of matrix-degrading enzymes.

Entities:  

Mesh:

Year:  1998        PMID: 9608324     DOI: 10.1097/00002281-199805000-00010

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  10 in total

Review 1.  Molecular mechanism of immune response, synovial proliferation and apoptosis in rheumatoid arthritis.

Authors:  T Hasunuma; T Kato; T Kobata; K Nishioka
Journal:  Springer Semin Immunopathol       Date:  1998

2.  Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation.

Authors:  W S Hou; Z Li; R E Gordon; K Chan; M J Klein; R Levy; M Keysser; G Keyszer; D Brömme
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

3.  IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion.

Authors:  E Lubberts; L A Joosten; M Chabaud; L van Den Bersselaar; B Oppers; C J Coenen-De Roo; C D Richards; P Miossec; W B van Den Berg
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

4.  The ICIDH-2 as a framework for the assessment of functioning and disability in rheumatoid arthritis.

Authors:  J Fransen; D Uebelhart; G Stucki; T Langenegger; M Seitz; B A Michel
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

5.  Proposal for a sonographic classification of target joints in rheumatoid arthritis.

Authors:  Klaus Lerch; Nicola Borisch; Christian Paetzel; Joachim Grifka; Wolfgang Hartung
Journal:  Rheumatol Int       Date:  2003-12-05       Impact factor: 2.631

6.  Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts.

Authors:  Elena Neumann; Birgit Riepl; Anette Knedla; Stephanie Lefèvre; Ingo H Tarner; Joachim Grifka; Jurgen Steinmeyer; Jurgen Schölmerich; Steffen Gay; Ulf Müller-Ladner
Journal:  Arthritis Res Ther       Date:  2010-05-12       Impact factor: 5.156

7.  Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis.

Authors:  J Schedel; O Distler; M Woenckhaus; R E Gay; B Simmen; B A Michel; U Müller-Ladner; S Gay
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

8.  Kinesin-like protein CENP-E is upregulated in rheumatoid synovial fibroblasts.

Authors:  F Kullmann; M Judex; W Ballhorn; H P Jüsten; D Wessinghage; J Welsh; T J Yen; B Lang; J C Hittle; M McClelland; S Gay; J Schölmerich; U Müller-Ladner
Journal:  Arthritis Res       Date:  1999-10-26

9.  Deficiency of fibroblast activation protein alpha ameliorates cartilage destruction in inflammatory destructive arthritis.

Authors:  Stefan Wäldele; Christina Koers-Wunrau; Denise Beckmann; Adelheid Korb-Pap; Corinna Wehmeyer; Thomas Pap; Berno Dankbar
Journal:  Arthritis Res Ther       Date:  2015-01-20       Impact factor: 5.156

10.  A myostatin-CCL20-CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis.

Authors:  Michelle Fennen; Toni Weinhage; Vanessa Kracke; Johanna Intemann; Georg Varga; Corinna Wehmeyer; Dirk Foell; Adelheid Korb-Pap; Thomas Pap; Berno Dankbar
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.